%0 Figure %A S. Patil, Sandeep %A Gentschev, Ivaylo %A Adelfinger, Marion %A Donat, Ulrike %A Hess, Michael %A Weibel, Stephanie %A Nolte, Ingo %A Frentzen, Alexa %A A. Szalay, Aladar %D 2012 %T Presence of immune cells in tumors of STSA-1 xenografted mice 7 days after GLV-1h68-, GLV-1h109- or PBS-treatments. %U https://plos.figshare.com/articles/figure/_Presence_of_immune_cells_in_tumors_of_STSA_1_xenografted_mice_7_days_after_GLV_1h68_GLV_1h109_or_PBS_treatments_/229178 %R 10.1371/journal.pone.0047472.g009 %2 https://ndownloader.figshare.com/files/558696 %K cells %K tumors %K stsa-1 %K xenografted %K mice %K days %K glv-1h109- %X

Percentage of (A) Gr-1highCD11b+ (MDSCs, granulocytes), (B) Gr-1intCD11b+ (MDSCs, monocytes), (C) F4/80+CD45+ (macrophages) or (D) MHCII+CD45+ (mainly B cells, macrophages and dendritic cells) cells in tumors of STSA-1 xenografted mice. Experiments were done twice with at least 3 mice per group. The data are presented as mean values +/- SD. The statistical significance was analyzed using one-way ANOVA followed Bonferronìs multiple comparison test (***P<0.001, **P<0.01, *P<0.05). The Anti-Gr-1 mAb (RB6-8C5) has long been used to stain MDSCs and allows the distinction of at least two subsets of granulocytes (Gr-1highCD11b+) and monocytic cells (Gr-1intCD11b+).

%I PLOS ONE